Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/7/09 → 10/7/12 |
Funding
- OSI Pharmaceuticals, Inc. (MEL-041509)
PROT# MEL-041509: Phase II Randomized, Double-Blind, Placebo-Controlled, Three-Arm,Dose-Finding, Study to Evaluate the Safety and Efficacy of Erlotinib in the Treatment of Moderate to Severe Psoriasis
- Laumann, Anne E (PD/PI)
- Singri, Prashant (Co-PD/PI)
- West, Dennis P (Co-PD/PI)
Project: Research project